Japan-headquartered global biopharmaceutical company, Takeda Pharmaceutical is exercising of its option to acquire London-based GammaDelta Therapeutics, a company focused on exploiting the unique properties of gamma delta (γδ) T cells…
Japan-headquartered global biopharmaceutical company, Takeda Pharmaceutical is exercising of its option to acquire London-based GammaDelta Therapeutics, a company focused on exploiting the unique properties of gamma delta (γδ) T cells…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


